CTI BioPharma Corp. (CTIC) News
Filter CTIC News Items
CTIC News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
CTIC News Highlights
- For CTIC, its 30 day story count is now at 2.
- Over the past 7 days, the trend for CTIC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- TG are the most mentioned tickers in articles about CTIC.
Latest CTIC News From Around the Web
Below are the latest news stories about CTI BIOPHARMA CORP that investors may wish to consider to help them evaluate CTIC as an investment opportunity.
Top Small-Cap Stocks for June 2023Biggest movers include Prometheus, TG Therapeutics, and Akero Therapeutics, all more than quadrupling in price in the last year while the Russell 2000 Index stays nearly unchanged. |
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of StockholdersCTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled the 2023 Annual Meeting of Stockholders (the "Annual Meeting") which was scheduled for June 21, 2023, and has withdrawn the proposals to have been submitted to stockholders at the Annual Meeting. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! |
Why Is Babylon (BBLN) Stock Down 57% Today?Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. |
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi. |
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up TodaySyneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors. |
Why Is SeaStar Medical (ICU) Stock Down 32% Today?SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA. |
Why Shares of CTI BioPharma Are Soaring WednesdayWhat happened Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF), also known as SOBI. |
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7BSwedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion. The transaction price represents an 89% premium to CTI's closing share price on May 9, 2023, and a 95% premium to its 30-trading day volume-weighted average price of $4.67. The transaction will diversify Sobi's portfolio of hematology medicines through CTI's lead product, Von |
CTI BioPharma Stock Soars After Agreeing to $1.7 Billion Sale. Biotech Deals Keep Coming.Swedish Orphan Biovitrum will buy CTI for $9.10 a share as it looks to expand its rare hematology portfolio. |